The FDA granted fast track designation to 64Cu-SAR-bisPSMA for PET imaging of PSMA-positive prostate cancer lesions in ...

Prostate cancer is one of the most prevalent cancers among men and poses a significant health concern, with its incidence on ...

Actor Colin Egglesfield has been diagnosed with cancer for the third time in his life. The former "All My Children" star ...

In 2024, Feng received the “Mentorship Award” from ASTRO. In December, the American Society for Clinical Oncology (ASCO) ...

Prostate cancer presents challenges in detection, treatment, and management. Learn about genetic risks, treatment resistance, ...

I am a 66-year-old white male who is active and relatively healthy. I have recently been diagnosed with prostate cancer.

US FDA grants fast track designation to Clarity Pharma’s Cu-64 SAR-bisPSMA in biochemical recurrence of prostate cancer: Sydney, Australia Monday, January 27, 2025, 14:00 Hrs [I ...

Despite a big increase in “watchful waiting” in the past 15 years, there’s a new study from the U.S. Department of Veterans Affairs health system shows that overtreatment of prostate cancer persists.

A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests - Decipher, Oncotype DX Genomic Prostate Score (GPS) and Prolaris - can help doctors make better decisions ...

Genomic tests are revolutionizing prostate cancer care, enabling precise, personalized treatment tailored to each patient.